The 20 Best Gallbladder Disease Doctors near Baltimore, MD

Gastroenterologist Mouen Khashab specializes in therapeutic endoscopy, and he oversees this group of practitioners across the Johns Hopkins enterprise. Nationally and internationally known in the field of interventional endoscopy, Dr. Khashab has contributed immensely to the field’s advancement as a minimally invasive means to treat gastrointestinal and pancreaticobiliary disorders. Dr. Khashab earned his medical degree from the American University of Beirut Faculty of Medicine, and subsequently completed a residency in internal medicine and a fellowship in gastroenterology at Indiana University. He then completed a two-year fellowship at The Johns Hopkins Hospital before joining the faculty in 2011. A busy researcher, Dr. Khashab has published more than 600 papers in peer-reviewed journals. In 2013, he described the procedure called gastric peroral endoscopic myotomy (known as G-POEM) and was able to disseminate and teach it all over the world. Other procedures that he expanded include peroral endoscopic myotomy (POEM), peroral endoscopic myotomy with fundoplication (POEM-F), Zenker’s peroral endoscopic myotomy (Z-POEM) and full thickness resection. In 2022, he received the Master Endoscopist Award from the American Society for Gastrointestinal Endoscopy (ASGE) for his numerous contributions to the field. His procedural expertise includes endoscopic retrograde cholangiopancreatography (ERCP), endoscopic ultrasound (EUS), interventional EUS, submucosal endoscopy, POEM/achalasia, endoscopic mucosal resection, endoscopic submucosal dissection, luminal stenting, large polyp resection and Barrett’s therapy, among others. Dr. Khashab is involved with multiple gastrointestinal societies and has served on many committees, including the ASGE Standards of Practice Committee, which is in charge of formulating guidelines for the practice of endoscopy. He has also served as an associate editor for the journal Endoscopy, a premier journal in the field. Khashab is a highly sought-after speaker at national and international conferences, and he has participated in multiple live endoscopy conferences. Outside of academic medicine, Dr. Khashab is an entrepreneur. His major interest is in new technology and medical devices, and his goal is to disrupt the field by introducing technology that makes endoscopic procedures safer, easier, efficient and more scalable. Dr. Khashab is rated as a Distinguished provider by MediFind in the treatment of Gallbladder Disease. His top areas of expertise are Achalasia, Pancreatic Pseudocyst, Bile Duct Obstruction, Endoscopy, and Gastric Bypass.

Dr. Cunningham earned his M.D. from George Washington University and completed general surgery residency at the University of Maryland. He has completed fellowships in both oncology research and pancreatic and hepatobiliary surgery at Johns Hopkins Hospital. Throughout his career, he has been a prolific contributor and editor with over 100 contributions to a variety of medical journals, guidelines, conferences and textbooks [see Research tab]. He has also served as a Cancer Liaison Physician for the American College of Surgeons, Commission on Cancer. A member the American College of Surgeons, the Society for American Gastrointestinal & Endoscopic Surgeons, the Americas Hepato-Pancreato-Biliary Association, the International Hepato-Pancreato-Biliary Association, the Society for Surgical Oncology, the Society for Surgery of the Alimentary Tract, and the Pancreas Club, Dr. Cunningham offers world-class multidisciplinary and minimally invasive evaluation and treatment of pancreatic, biliary and liver diseases, both benign and malignant. LinkedIn https://www.linkedin.com/in/stevenccunningham. Dr. Cunningham is rated as a Distinguished provider by MediFind in the treatment of Gallbladder Disease. His top areas of expertise are Biliary Dyskinesia, Gallbladder Disease, Pancreatic Cancer, Gallbladder Removal, and Pancreaticoduodenectomy.

Dr. Nilofer S. Azad is Professor of Oncology at Johns Hopkins University School of Medicine and serves as the Associate Cancer Center Director for Clinical Research for the Johns Hopkins Sidney Kimmel Cancer Center. Dr. Azad earned her medical degree and completed a residency in internal medicine at Baylor College of Medicine in Houston, Texas. She then completed a fellowship in oncology and hematology at the National Institute of Health's National Cancer Institute in Bethesda, Maryland where she served as chief fellow. Dr. Azad’s research focused on early phase drug development and the intersection of moving exciting laboratory findings into patients for new treatment options Dr. Azad joined the faculty at the Kimmel Cancer Center in 2008. Dr. Azad’s clinical expertise is in cancers of the gastrointestinal tract, with a concentration in colorectal cancer, cholangiocarcinoma and pancreaticobiliary tract cancer. Her research efforts are dedicated to developing new drug combinations for patients with advanced cancer. In particular, Dr. Azad’s laboratory and clinical trials explore epigenetic therapy in combination with chemotherapy and immunotherapy to improve survival for patients, as well as molecularly targeted drugs. She is an active clinical trialist, leading multiple clinical trials of molecularly targeted agents for advanced cancer patients. Dr. Azad has received numerous grants for her work from entities such as the NCI (National Cancer Center), American Cancer Society, American Society of Clinical Research, Breakthrough Cancer Foundation, the Lustgarten Foundation, The Gateway Foundation, and the National Comprehensive Cancer Network, among others. She served as Principal for Johns Hopkins on the AACR Stand Up 2 Cancer Colorectal Cancer Dream Team and is a member of the Stand Up 2 Cancer Epigenetics Dream Team, leading the GI cancer initiatives for the group. Dr. Azad is a national leader in GI cancer, including serving as a member of the national NCI Colon Cancer Task Force and as Co-Chair of the Scientific and Medical Advisory Board for the Cholangiocarcinoma Foundation. She has a presidential appointment to the National Cancer Advisory Board. Dr. Azad is rated as an Advanced provider by MediFind in the treatment of Gallbladder Disease. Her top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Colorectal Cancer, Pancreatic Cancer, Hepato-Pancreato-Biliary Surgery, and Colonoscopy.

Dr. Marc Paul specializes in diagnostic body imaging with more than 30 years of experience in various private practice settings. Dr. Paul earned his medical degree from the University of Maryland School of Medicine. Following an internal medicine internship and residency at Sinai Hospital, he completed a residency in diagnostic radiology at the University of Louisville School of Medicine. He went on to a fellowship in cross-sectional imaging at the Johns Hopkins University School of Medicine. Dr. Paul joined the diagnostic faculty in March 2022. Dr. Paul is rated as an Advanced provider by MediFind in the treatment of Gallbladder Disease. His top areas of expertise are Gallbladder Disease, Pleurisy, Pleural Effusion, and Progressive Familial Intrahepatic Cholestasis Type 1.

Gastroenterologist Saowanee Ngamruengphong specializes in the endoscopic diagnosis and management of gastrointestinal malignancies, premalignant and malignant lesions in the gastrointestinal tract (e.g., early gastric cancer, Barrett's esophagus-associated neoplasia), esophageal cancer, colon polyps or early colorectal cancer, and pancreatic and biliary disease. Dr. Ngamruengphong earned a medical degree from Chulalongkorn University and completed residency training at the Texas Tech University Health Sciences Center. She undertook fellowship training in gastroenterology at the Mayo School of Graduate Medical Education and further fellowship training in therapeutic endoscopy at The Johns Hopkins Hospital. Her research interests include endoscopic resection and the management of precancerous or cancerous gastrointestinal lesions. Dr. Ngamruengphong is a member of several professional organizations, including the Thai Medical Council, the American College of Gastroenterology and the American Gastroenterological Association. Videos Endoscopic Submucosal Dissection (ESD) — Eileen’s Story Recent News Articles and Media Coverage A Rare, Stomach-Saving Endoscopic Procedure, Inside Tract (Spring 2021) Case Presentation: ESD-TAMIS, Inside Tract (Spring 2019) Innovative Approaches to Colorectal Surgery Benefit Patients, Surgery (Winter 2019) For Colorectal Polyps: Early Detection and Minimally Invasive Endoscopic Resection, Inside Tract (Winter, 2019) The Cutting Edge of Endoscopic Resection, Inside Tract (Spring, 2017) Stomach Cancer: Know Your Risks & Treatment Options, Johns Hopkins Surgery (4/26/2017). Dr. Ngamruengphong is rated as an Advanced provider by MediFind in the treatment of Gallbladder Disease. Her top areas of expertise are Achalasia, Pancreatic Pseudocyst, Stomach Cancer, Endoscopy, and Gastric Bypass.

Dr. Duncan specializes in gastrointestinal surgical oncology, including surgery of the esophagus, stomach, intestine, colon and rectum, gallbladder and pancreas, adrenal and retroperitoneal sarcoma. He has national and international expertise in gastric cancer and hereditary gastric cancer including CDH-1. He wrote the Johns Hopkins Patient Guide for Cancer of the Stomach and Esophagus. Dr. Duncan gives lectures and presentations nationally and internationally on Gastric and GI cancer surgery and works with Johns Hopkins International on cancer programs and centers overseas. Dr. Duncan is rated as an Advanced provider by MediFind in the treatment of Gallbladder Disease. His top areas of expertise are Stomach Cancer, Familial Colorectal Cancer, Gastrointestinal Stromal Tumor, Gastrectomy, and Hernia Surgery.

Mariuxi Manukyan, M.D., is an assistant professor of surgery at Johns Hopkins, working primarily with the Division of Acute Care Surgery. Dr. Manukyan’s areas of clinical expertise include critical care, general surgery and trauma. Before joining Johns Hopkins, Dr. Manukyan was an acute care surgery fellow with the Department of Critical Care and Acute Care Surgery at The University of Texas Medical Center in Houston. Dr. Manukyan received her undergraduate degree from Brown University and earned her medical degree from Brown Alpert Medical School. She completed her residency at Indiana University and fellowships in acute care surgery and surgical critical care at UT Houston Medical Center. She is a member of the Association for Academic Surgery, the American College of Surgeons, the Pan American Trauma Society, the American Association for the Surgery of Trauma, and the Eastern Association for the Surgery of Trauma. Dr. Manukyan’s research interests include the field of geriatric trauma, specifically in identifying the specific risks associated within the geriatric trauma population and in finding in-hospital methods to decrease the morbidity and mortality associated with this patient population. Dr. Manukyan is rated as an Experienced provider by MediFind in the treatment of Gallbladder Disease. Her top areas of expertise are Gastrointestinal Fistula, Hernia, Ogilvie Syndrome, Gastrostomy, and Hernia Surgery.

Jin He, M.D., Ph.D., is a professor of surgery at the Johns Hopkins University School of Medicine and is the Division Chief of Hepato-Pancreato-Biliary & Gastrointestinal Surgical Oncology. Dr. He specializes in diseases and tumors of the pancreas, liver, bile duct, and gallbladder. He performs open as well as minimally invasive (robotic and laparoscopic) surgery, including the Whipple procedure. Dr. He received his medical degree from Beijing Medical University and a Ph.D. in oncology from Fudan University Shanghai Medical College. He completed the Halsted general surgery residency training at Johns Hopkins, followed by an ACGME accredited fellowship in complex general surgical oncology at Johns Hopkins. Dr. He is the John Cameron Professor of Alimentary Tract Diseases. Dr. He’s research focuses on personalized treatment through stratifying pancreatic tumors on their genetic features. He holds several patents in anti-cancer vascular targeting agents and has published extensively in peer-reviewed journals and lectured internationally. He serves on several national committees, including the NCCN panel on neuroendocrine tumors and the Alliance for Clinical Trials in Oncology. Dr. He is rated as an Experienced provider by MediFind in the treatment of Gallbladder Disease. His top areas of expertise are Pancreatic Cancer, Neuroendocrine Tumor, Cholangiocarcinoma (Bile Duct Cancer), Pancreatectomy, and Pancreaticoduodenectomy.

Alistair Kent, M.D., M.P.H., joins Johns Hopkins as assistant professor of surgery and trauma surgeon at Johns Hopkins Bayview Medical Center. Dr. Kent’s areas of clinical expertise include general surgery, trauma and acute care surgery, surgical critical care, and surgical care of medically fragile patients. Dr. Kent earned bachelor of science degrees in chemistry and mathematics from Harding University. He received his medical degree from Washington University School of Medicine and went on to earn his master of public health degree from George Washington University School of Public Health and Health Services. He completed his general surgery residency at Ohio State University, Wexner Medical Center and a trauma and acute care surgery fellowship at The Johns Hopkins Hospital. He is a member of several professional societies, including the Eastern Association for the Surgery of Trauma, the Society of Critical Care Medicine, the American College of Surgeons, the Association for Academic Surgery, Academy Health, and the American Medical Association. Dr. Kent’s research interests include studies of health care delivery systems, health care economics, geographic analysis, trauma care, and systems of care for patients with life-threatening or time sensitive illness. Selected Publications Kent A, Bahner DP, Boulger CT, Eiferman DS, Adkins EJ, Evans DC, Springer AN, Balakrishnan JM, Valiyaveedan S, Galwankar S, Njoku C, Lindsey DE, Yeager S, Roelant GJ, Stawicki SP. Sonographic evaluation of intravascular volume status in the surgical intensive care unit: a prospective comparison of subclavian vein and inferior vena cava collapsibility index. J Surg Res 2013; 184(1):561-6. PMID: 23764308 Kent A, Patil P, Davila V, Bailey JK, Jones C, Evans DC, Boulger CT, Adkins E, Balakrishnan JM, Valiyaveedan S, Galwankar SC, Bahner DP, Stawicki SP. Sonographic evaluation of intravascular volume status: Can internal jugular or femoral vein collapsibility be used in the absence of IVC visualization? Annals of Thoracic Medicine. 2015; 10(1): 44-49 PMID: PMC4286845 Genin G, Kent A, Birman V, Wopenka B, Pasteris J, Marquez P, Thomopoulos S. Functional grading of mineral and collagen in the attachment of tendon to bone. Biophysical Journal 2009; 97(4): 976-985 PMID: 19094386 Stawicki S, Kent A, Patil P, Jones C, Stoltzfus J, Vira A, Kelly N, Springer A, Vazquez D, Evans D, Papadimos T, Bahner, D. Dynamic behavior of venous collapsibility and central venous pressure during standardized crystalloid bolus: A prospective, observational pilot study. Int J Crit Illn Inj Sci. 2015; 5(2): 80-84 PMID: PMC4477400 Wopenka B, Kent A, Pasteris J, Yoon Y, Thomopoulos S. The tendon-to-bone transition of the rotator cuff: a preliminary Raman spectroscopic study documenting the gradual mineralization across the insertion in rat tissue samples. Applied Spectroscopy 2008; 62(12): 1285-1294 PMID: 19094386. Dr. Kent is rated as an Experienced provider by MediFind in the treatment of Gallbladder Disease. His top areas of expertise are Hernia, Gallstones, Gallbladder Disease, Hernia Surgery, and Gastrostomy.

Kelly Lafaro, MD, MPH, is a general surgeon with a specialty in gastrointestinal surgical oncology and hepatobiliary surgery. She is part of the Johns Hopkins Kimmel Cancer Center. Dr. Lafaro earned her medical degree from Tulane University School of Medicine and completed her residency at New York-Presbyterian/Columbia University Irving Medical Center. Her fellowship in complex general surgical oncology was completed at City of Hope National Medical Center. Dr. Lafaro’s expertise includes pancreatic adenocarcinoma, neuroendocrine tumors, minimally invasive pancreatic and liver surgeries, and colorectal liver metastases. In addition to her clinical experience, Dr. Lafaro is published in the field of liver and pancreatic cancer. She is interested in the improvement of surgical and post-surgical outcomes. Dr. Lafaro is rated as an Experienced provider by MediFind in the treatment of Gallbladder Disease. Her top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Neuroendocrine Tumor, Pancreatectomy, and Pancreaticoduodenectomy.

Dr. Benjamin Philosophe is the surgical director of the Johns Hopkins Comprehensive Transplant Center. He also serves as the lead transplant surgeon at Sibley Memorial Hospital’s Hepatology Multidisciplinary Center. Dr. Philosophe was the first physician to perform robotic total right and total left hepatic resections in the state of Maryland. He has expanded the application of minimally invasive surgical approaches to other hepatobiliary diseases and has improved outcomes and reduced effects of surgery on these patients. Dr. Philosophe practices out of The Johns Hopkins Hospital in Baltimore, Md., as well as Johns Hopkins Community Physician locations in Bethesda, Md. and Lutherville, Md. He is also affiliated with Suburban Hospital and Johns Hopkins Howard County Medical Center. Dr. Philosophe has a wide range of expertise, including cirrhosis; hepatic surgery, hepatitis, hepatobiliary conditions and surgeries; biliary tract surgery and hepatopancreatobiliary surgery; laparoscopic surgeries; vascular surgery; and robotic surgeries. He also has an expertise in various kinds of transplant surgeries, such as kidney, live donor liver, liver and pancreas, as well as various kinds of cancer, such as bile duct, gallbladder, hepatocellular, liver and pancreatic. Dr. Philosophe earned his medical degree from Boston University School of Medicine. He completed a residency in general surgery at Barnes-Jewish Hospital, followed by a liver transplantation fellowship at the University of Toronto. Dr. Philosophe also completed a transplant surgery fellowship at the University of Maryland, where he went on to work as a professor of surgery and the head of liver transplantation and hepatobiliary surgery. Dr. Philosophe is a member of the American Board of Surgery, the Clinical Robotic Surgery Association, the American Society of Transplant Surgeons, the Transplantation Society and the International Liver Transplantation Society. He has earned a Super Doctors Award in general surgery from the Washington Post Magazine, as well as a Top Doctor Award for hepatobiliary surgery and transplant specialists from Baltimore Magazine. Dr. Philosophe has also been repeatedly named one of America’s Top Doctors and one of America’s Top Doctors for Cancer by Castle Connolly. Dr. Philosophe has contributed to numerous publications and presentations. His research interests include uncovering the mechanisms that contribute to transplant rejection and determining characteristics that can be used to better predict donor organ function. He has completed pioneering work in developing a scoring system called the Maryland Aggregate Pathology Index (MAPI), which is used by transplant surgeons worldwide to assess the likelihood of a deceased donor’s kidney function after transplantation. MAPI has increased the utilization of donor kidneys and saved many lives. Dr. Philosophe is rated as an Experienced provider by MediFind in the treatment of Gallbladder Disease. His top areas of expertise are Hepatitis, Liver Failure, End-Stage Renal Disease (ESRD), Liver Transplant, and Kidney Transplant.

Lilah Morris-Wiseman, M.D., F.A.C.S., is an endocrine surgeon who serves as chief of the Division of Endocrine Surgery. Dr. Morris-Wiseman came to Johns Hopkins in 2021 from the University of Arizona College of Medicine where she was an Associate Professor of Endocrine Surgery. She has a broad endocrine surgery practice using minimally invasive techniques as appropriate to facilitate excellent clinical outcomes with rapid patient recovery. Her clinical practice emphasizes patient-centered shared decision-making and excellent communication and multidisciplinary collaboration so that a patient’s surgical care occurs within an individualized context. She has been named an associate member of the American College of Surgeons' Academy of Master Surgeon Educators. Awardees are recognized for having devoted their careers to surgical education and are considered premier leaders in their respective fields. Dr. Morris-Wiseman holds committee responsibilities with multiple national organizations including the American Thyroid Association, the American Association of Endocrine Surgeons, and the Association of Program Directors in Surgery. She serves on the editorial board of Clinical Thyroidology, is a reviewer for multiple journals, and has published over 50 peer-reviewed manuscripts and book chapters. Dr. Morris-Wiseman sees patients at the Johns Hopkins Outpatient Center in Baltimore and the Johns Hopkins Health Care & Surgery Center – Green Spring Station in Lutherville. To support Dr. Morris-Wiseman's research, visit: https://secure.jhu.edu/form/morris-wiseman. Dr. Morris is rated as an Experienced provider by MediFind in the treatment of Gallbladder Disease. Her top areas of expertise are Hyperparathyroidism, Familial Isolated Hyperparathyroidism, Neonatal Severe Hyperparathyroidism, Thyroidectomy, and Parathyroidectomy.

Dr. Stevens is an Associate Professor of Surgery at the Johns Hopkins School of Medicine and an attending surgeon at The Johns Hopkins Hospital. Dr. Stevens obtained his medical degree from the University of Arizona where he also completed his residency in general surgery. He subsequently completed a fellowship in Trauma/Surgical Critical Care at the University of Maryland, R. Adams Cowley Shock Trauma Center. During his fellowship, Dr. Stevens completed a Master of Public Health degree at the Johns Hopkins Bloomberg School of Public Health. Dr. Stevens’ research interests center on surgical and trauma-care strengthening in resource-poor settings. Dr. Stevens is rated as an Experienced provider by MediFind in the treatment of Gallbladder Disease. His top areas of expertise are Ogilvie Syndrome, Gastrointestinal Perforation, Gastrointestinal Fistula, Hernia Surgery, and Colostomy.

Dr. Kelvin K. Hong is an Associate Professor and Executive Vice Chair of Radiology within the Johns Hopkins Department of Radiology. A specialist in interventional and vascular radiology, Dr. Hong serves as the Medical Director of the Johns Hopkins Interventional Radiology Center. Dr. Hong earned his medical degree from South Africa’s University Of Witwatersrand Medical School in Parktown. He completed a radiology residency at Parktown West’s College of Medicine/Radiology, as well as a cardiovascular/interventional radiology fellowship and diagnostic radiology residency at The Johns Hopkins Hospital. His areas of clinical expertise include bone, liver and soft-tissue tumors; chronic total occlusions; claudication; deep venous thrombosis; lung, esophageal and kidney cancer; peripheral arterial/vascular disease; renal artery/vascular disease; uterine fibroid tumors; varicocele; and vascular malformations and venous thromboembolism. Dr. Hong performs procedures that include radiofrequency ablation for lung, liver, kidney and bone lesions; transcatheter arterial chemoembolization for liver cancer; lower-extremity angioplasty and stenting; visceral angioplasty and stenting; embolization of uterine fibroid tumors; cryoablation for pain control; and percutaneous laser ablation of varicose veins. Dr. Hong served as editor for the book Percutaneous Tumor Ablation and contributed to Interventional Oncology: Principles and Practice. Dr. Hong is rated as an Experienced provider by MediFind in the treatment of Gallbladder Disease. His top areas of expertise are Fibrolamellar Carcinoma, Bile Duct Obstruction, Neuroendocrine Tumor, Liver Embolization, and Pancreaticoduodenectomy.

William Burns, M.D., is an assistant professor of surgery at the Johns Hopkins University School of Medicine and a surgeon within the Division of Hepato-Pancreato-Biliary & Gastrointestinal Surgical Oncology at The Johns Hopkins Hospital. Prior to joining the faculty at Johns Hopkins, Dr. Burns served as an assistant professor of surgery at the University of Michigan, as well as an attending physician at the University of Michigan Health Systems and the VA Ann Arbor Healthcare System. Dr. Burns received his medical degree from Yale University School of Medicine and was awarded a research training fellowship by the Howard Hughes Medical Institute. He completed an internship and residency in general surgery at The Johns Hopkins Hospital followed by clinical fellowship training in complex general surgical oncology at The University of Texas MD Anderson Cancer Center. Additionally, he completed postgraduate research fellowships in the field of cancer immunotherapy and tumor immunology at the National Cancer Institute and the MD Anderson Cancer Center. Dr. Burns specializes in treating patients with tumors of the pancreas and gastrointestinal tract, sarcoma and melanoma. He is trained in traditional and minimally invasive surgical techniques. Furthermore, he works closely with colleagues in medical and radiation oncology to provide comprehensive cancer care. His research focuses on immune cell-tumor cell interactions to improve outcomes in patients with pancreatic cancer, cancer immunotherapy for solid tumors, the role of lymph node surgery in the treatment of cancer, and human biospecimen analysis to guide therapy in patients with cancer. He is a member of several professional societies, including the American College of Surgeons, Society of Surgical Oncology, Association of Academic Surgery, and Society of Immunotherapy for Cancer. Dr. Burns is rated as an Experienced provider by MediFind in the treatment of Gallbladder Disease. His top areas of expertise are Neuroendocrine Tumor, Familial Pancreatic Cancer, Familial Colorectal Cancer, Small Bowel Resection, and Pancreatectomy.

Dr. Narang is an Assistant Professor in the Johns Hopkins Department of Radiation Oncology & Molecular Sciences. A former chief resident in the department, Dr. Narang now specializes in radiation treatment for gastrointestinal malignancies, including pancreatic cancer, colorectal cancer, hepatobiliary malignancies, and gastric cancer. Dr. Narang has an interest in expanding multi-disciplinary care for patients with gastrointestinal malignancies. Make A Gift. Dr. Narang is rated as an Experienced provider by MediFind in the treatment of Gallbladder Disease. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatoblastoma, Pancreaticoduodenectomy, and Pancreatectomy.

Gina Adrales, M.D., M.P.H., joins the Johns Hopkins Department of Surgery as Director of the Division of Minimally Invasive Surgery, Director of the Minimally Invasive Surgery Training and Innovation Center, and Co-Director of the Johns Hopkins Bariatric Surgery Fellowship. Her areas of clinical expertise include gastroesophageal reflux disease (GERD), gallbladder disease, achalasia, splenectomy (spleen removal), benign gastric and intestinal surgery, bariatric surgery, and open and laparoscopic hernia repair (inguinal, ventral, incisional, umbilical, hiatal, paraesophageal). Dr. Adrales has been named an associate member of the American College of Surgeons' Academy of Master Surgeon Educators. Awardees are recognized for having devoted their careers to surgical education and are considered premier leaders in their respective fields. Prior to joining Johns Hopkins, Dr. Adrales was on faculty at Dartmouth where she directed the Surgery Clerkship, the Hernia Surgery Center, and the Bariatric Surgery Program. During her tenure at Dartmouth, she earned her Masters of Public Health at The Dartmouth Institute for Health Policy and Clinical Practice. She received her undergraduate degree from the College of William and Mary and her medical degree from the University of Virginia. She completed her residency at the Carolinas Medical Center and a research and clinical fellowship in minimally invasive surgery at the University of Kentucky before her first faculty appointment at the Medical College of Georgia. A national leader in hernia surgery, Dr. Adrales serves on the Executive Council of the Americas Hernia Society and previously served on the Executive Council of the Americas Hernia Society Quality Collaborative to improve the safety and quality of hernia surgery. She is actively involved in a number of committees for the Society of American Gastrointestinal and Endoscopic Surgeons including various roles in surgical education, the development of the Fundamentals of Endoscopic Surgery and an innovative interactive hernia surgery education module. Dr. Adrales’ research interests include health services research, clinical outcomes and quality improvement in minimally invasive foregut surgery, bariatric and metabolic surgery, and abdominal wall reconstruction. She has presented her work regionally, nationally, and internationally. Dr. Adrales is rated as an Experienced provider by MediFind in the treatment of Gallbladder Disease. Her top areas of expertise are Hernia, Hiatal Hernia, Gastroparesis, Gastrectomy, and Sleeve Gastrectomy.

Richard Burkhart, M.D., is an Associate Professor of Surgery at The Johns Hopkins Hospital with a focus on complex minimally-invasive surgery and research for cancers of the pancreas, liver and bile ducts. Dr. Burkhart received his medical degree from Boston University and completed his surgical residency and research fellowships at the Thomas Jefferson University Hospital in Philadelphia and the Cold Spring Harbor Laboratories. He is a member of several professional organizations, including the American Association of Cancer Research, the American College of Surgeons, the Society of Surgery for the Alimentary Tract, the Pancreas Club, and the Society of Surgical Oncology. Outside the operating room, Dr. Burkhart heads a multidisciplinary laboratory team dedicated to bringing next-generation precision medicine approaches into the routine clinical care of patients that we serve. He has a particular research interest in using personalized models of pancreas cancer, made from tumor during and immediately after surgical resection, to select the best chemotherapy for each patient to support long-term survival and improve rates of disease cure. The laboratory team, funded in part by the National Institutes of Health, the National Cancer Institute, the Lustgarten Foundation and Stand Up to Cancer, is also thankful to the many patients who have supported the work through philanthropic gift. Dr. Burkhart is rated as an Experienced provider by MediFind in the treatment of Gallbladder Disease. His top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Familial Pancreatic Cancer, Pancreatectomy, and Pancreaticoduodenectomy.

Jeffrey Hirsch is a Radiologist in Baltimore, Maryland. Dr. Hirsch is rated as an Advanced provider by MediFind in the treatment of Gallbladder Disease. His top areas of expertise are Ascites, Visceromegaly, Retroversion of the Uterus, and Angiomyoma.

Recai Aktay is a Radiologist in Baltimore, Maryland. Dr. Aktay is rated as an Advanced provider by MediFind in the treatment of Gallbladder Disease. His top areas of expertise are Retroversion of the Uterus, Gallbladder Disease, Biliary Dyskinesia, and Ascites.